CD24 expression predicts poor prognosis for patients with cutaneous malignant melanoma

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 11, 2014, Pages 4337-4341

  Tang, Ming Rui ^a   Wang, Yu Xin ^a   Guo, Shu ^a   Han, Si Yuan ^a   Li, He Huan ^a   Jin, Shi Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CD24; Melanoma; Prognosis

Indexed keywords

CD24 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PREDICTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; WESTERN BLOTTING;

EID: 84918508302     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Garbe C and Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
2. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ and Sondak VK. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
3. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H and Sleeman JP. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 2005; 65: 10783-10793.
4. Bircan S, Kapucuoglu N, Baspinar S, Inan G and Candir O. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Pathol Res Pract 2006; 202: 569-576.
5. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H and Dietel M. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003; 9: 4906-4913.
6. Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M and Kristiansen G. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 2005; 11: 6574-6581.
7. Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH and Yuan RH. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Ann Surg Oncol 2007; 14: 2748-2758.
8. Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, Dahl E, Hinzmann B, Specht T, Pervan J, Stephan C, Loening S, Dietel M and Rosenthal A. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 2005; 205: 359-376.
9. Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M and Petersen I. CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 2003; 88: 231-236.
10. Kristiansen G, Sammar M and Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004; 35: 255-262.
11. Tarhini AA and Agarwala SS. Cutaneous melanoma: available therapy for metastatic disease. Dermatol Ther 2006; 19: 19-25.
12. Fecher LA and Flaherty KT. Where are we with adjuvant therapy of stage III and IV melanoma in 2009? J Natl Compr Canc Netw 2009; 7: 295-304.
13. Lee HJ, Choe G, Jheon S, Sung SW, Lee CT and Chung JH. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification. J Thorac Oncol 2010; 5: 649-657.
14. Mylona E, Giannopoulou I, Fasomytakis E, Nomikos A, Magkou C, Bakarakos P and Nakopoulou L. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+tumor cells in invasive breast carcinomas. Hum Pathol 2008; 39: 1096-2102.
15. Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A and Hegardt C. The CD44+/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Res 2008; 10: R53.
16. Jacob J, Bellach J, Grutzmann R, Alldinger I, Pilarsky C, Dietel M and Kristiansen G. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 2004; 4: 454-460.
17. Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K and Tanaka M. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas. Hum Pathol 2010; 41: 1466-1474.